- Home
- TSHA vs RDVT Comparison
TSHA vs RDVT Comparison
Compare TSHA & RDVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- RDVT
- Stock Information
- Founded
- TSHA 2019
- RDVT 2017
- Country
- TSHA United States
- RDVT United States
- Employees
- TSHA N/A
- RDVT N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- RDVT Computer Software: Prepackaged Software
- Sector
- TSHA Health Care
- RDVT Technology
- Exchange
- TSHA Nasdaq
- RDVT Nasdaq
- Market Cap
- TSHA 728.4M
- RDVT 649.4M
- IPO Year
- TSHA 2020
- RDVT N/A
- Fundamental
- Price
- TSHA $2.65
- RDVT $44.46
- Analyst Decision
- TSHA Strong Buy
- RDVT
- Analyst Count
- TSHA 6
- RDVT 0
- Target Price
- TSHA $8.17
- RDVT N/A
- AVG Volume (30 Days)
- TSHA 2.6M
- RDVT 90.4K
- Earning Date
- TSHA 08-11-2025
- RDVT 08-06-2025
- Dividend Yield
- TSHA N/A
- RDVT 0.68%
- EPS Growth
- TSHA N/A
- RDVT N/A
- EPS
- TSHA N/A
- RDVT 0.61
- Revenue
- TSHA $7,224,000.00
- RDVT $79,681,000.00
- Revenue This Year
- TSHA N/A
- RDVT $18.86
- Revenue Next Year
- TSHA N/A
- RDVT $13.99
- P/E Ratio
- TSHA N/A
- RDVT $72.54
- Revenue Growth
- TSHA N/A
- RDVT 26.30
- 52 Week Low
- TSHA $1.05
- RDVT $21.83
- 52 Week High
- TSHA $3.31
- RDVT $52.24
- Technical
- Relative Strength Index (RSI)
- TSHA 56.06
- RDVT 38.29
- Support Level
- TSHA $2.34
- RDVT $44.00
- Resistance Level
- TSHA $2.81
- RDVT $45.40
- Average True Range (ATR)
- TSHA 0.16
- RDVT 1.32
- MACD
- TSHA 0.01
- RDVT -0.39
- Stochastic Oscillator
- TSHA 67.37
- RDVT 7.27
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About RDVT Red Violet Inc.
Red Violet Inc is a software and services company. It specializes in data analysis, providing cloud-based, mission-critical information solutions to enterprises in a variety of industries. Through its CORE data fusion platform, it provides mission-critical information about individuals, businesses and assets.